Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD(+) in healthy middle-aged and older adults Journal Article uri icon

Overview

publication date

  • March 29, 2018

Full Author List

  • Martens CR; Denman BA; Mazzo MR; Armstrong ML; Reisdorph N; McQueen MB; Chonchol M; Seals DR

Other Profiles

Additional Document Info

volume

  • 9